| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |